Prescribing and deprescribing to sustain brain health in older adults
This event is in the past.
April 11, 2023
9:30 p.m. to 10:30 p.m.
9:30 p.m. to 10:30 p.m.
Event category: Seminar
Join WSU, Institute of Gerontology 2023 Spring Colloquia Series for:
Prescribing and Deprescribing to Sustain Brain Health in Older Adults
Noll Campbell, PhD
Associate Professor for Pharmacy Practice, Purdue University, Faculty Associate, Indiana University Center on Center on Aging and Life Course
With a research focus on medication use that optimizes brain health, Dr. Campbell will address ongoing and future research activities within his lab that intend to prevent cognitive impairment and improve decisions about medications use in older persons. This will be accomplished by identifying the potential patterns of antihypertensive treatments that may reduce the risk of dementia. Next, Dr. Campbell will identify medications thought to contribute to dementia risk and an ongoing study testing the impact of a deprescribing intervention on cognition in community-dwelling older adults. A description of the flow of the intervention and lessons learned to date will follow. Lastly, a brief description of tech-based approaches to deprescribing will also be introduced to round out the session.
Dr. Noll Campbell in an Associate Professor in the Department of Pharmacy Practice at Purdue University, an Investigator at the Indiana University Center for Aging Research at the Regenstrief Institute, and a Scientist with the Indiana University Center for Health Innovation and Implementation Science. His research is focused on the measurement and management of adverse cognitive effects of medications in older adults with acute and chronic cognitive impairment. This work includes the use of behavioral economic principals to evaluate the impact of deprescribing interventions on clinical and operational outcomes in various care environments. His work has been funded by the National Institute of Health’s National Institute on Aging, the Agency for Healthcare Research and Quality, and the pharmaceutical industry. He was awarded a New Investigator Award from the American Geriatrics Society in 2012, a Hulman Award for Achievement in Geriatrics from the Indiana Public Health Association in 2014, a Departmental Best Paper Award in 2019, and the Chaney Family Early Scholar Award from the Purdue University College of Pharmacy in 2021. Dr. Campbell also serves as the President-Elect of the American Delirium Society.
Meeting ID: 981 1740 1498